Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | TTR | P02766 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5856395 | 0.92 | PTPN1 (0.37) | PTPN1KCNH2TRPV1ESR1ESR2 | |
| SCHEMBL8521150 | 0.90 | PTPN1 (0.34) | PTPN1KCNH2TRPV1 | |
| SCHEMBL7588462 | 0.83 | ESR1 (0.31) | ESR1ESR2 | |
| SCHEMBL7589438 | 0.81 | PTPN1 (0.37) | PTPN1KCNH2TRPV1ESR1ESR2 | |
| SCHEMBL7587802 | 0.80 | PPARG (0.33) | PTPN1KCNH2TRPV1 | |
| SCHEMBL7589364 | 0.79 | PPARG (0.33) | PTPN1KCNH2TRPV1 | |
| SCHEMBL5854628 | 0.78 | PPARG (0.32) | PTPN1 | |
| SCHEMBL5856143 | 0.78 | PPARG (0.32) | PTPN1 | |
| SCHEMBL2570060 | 0.78 | ALOX15 (0.44) | KCNH2TRPV1ESR1ESR2TTR | |
| SCHEMBL7588458 | 0.77 | ESR1 (0.43) | KCNH2ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0944613-A1 | NOVEL BENZOPYRAN DERIVATIVES | C & C Research Laboratories (KR) | 1999-09-29 | — | — | EP | disclosed |
| WO-1998025916-A1 | NOVEL BENZOPYRAN DERIVATIVES | C & C RESEARCH LABORATORIES (KR) | 1998-06-18 | — | — | WO | disclosed |